Tehran University of Medical Sciences

Science Communicator Platform

Faculty Members have conducted research related to the Comparing Efficacy and Safety of P013, a Proposed Pertuzumab Biosimilar, With the Reference Product in Her2-Positive Breast Cancer Patients: A Randomized, Phase Iii, Equivalency Clinical Trial
Tahereh Yavari
Tahereh Yavari

Assistant Professor of Internal Medicine

Department Internal Medicine

School of Medicine

Shariati Hospital

Tehran University of Medical Sciences